Innovative Visionary Mark W. Womack Strengthens Bridgewest Perth Pharma Pty Ltd Board, Amplifying NovaCina’s Growth Vision

Mark W. Womack Named to Bridgewest Perth Pharma Pty Ltd Board of Directors  (Miami and Perth, Australia, March 5, 2024) Bridgewest Perth Pharma, a global pharmaceutical supply and manufacturing company, with subsidiaries NovaCina and LumaCina, announced today the appointment of Mark W. Womack as a…